Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Chlorphenesin carbamate + hydroxychloroquine by Oncocross for Metastatic Pancreatic Cancer: Likelihood of Approval
Chlorphenesin carbamate + hydroxychloroquine is under clinical development by Oncocross and currently in Phase I for Metastatic Pancreatic Cancer. According...